Document is current

Article History

Received: 13 September 2019

Accepted: 29 October 2020

First Online: 1 December 2020

Ethics approval and consent to participate

: Source of cell lines and tissues: W12 subclones (20850, 20822, 201402, 20861 and 20862) and J2 3T3 mouse embryo fibroblasts were a kind gift of Dr. Paul Lambert (University of Wisconsin, Madison, WI). MCF7 and MCF7(Her2) cells were a kind gift of Dr. Dennis Slamon (UCLA, Los Angeles, CA). HeLa and MDA-MB-453 cell lines were purchased from ATCC (Manassas, VA). Human EpiVaginal tissues were purchased from MatTek (Ashland, MA).

: N/A.

: The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. Supplementary information is available at the <i>British Journal of Cancer</i>’s website.

: M.R.C. is listed on an application filed under the Patent Cooperation Treaty for TriCurin, filing no. PCT/US14/67819 for activity-enhancing curcumin composition and methods of use. Publication number WO/2015/081319.

: This work was supported by a National Institute of General Medical Sciences (NIGMS) (GM113782 grant (S.R.). The contents of this paper are solely our responsibility and do not necessarily reflect the official views of the NIGMS. The funding sources had no involvement in study design; the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.